Joseph L. Goldstein - Director at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class
Common Stock	6.55K	$4.64M	$708.19	Jan 2, 2025	Direct
Non-Qualified Stock Option (right to buy)	1.96K			Jan 2, 2025	Direct	Common Stock
Non-Qualified Stock Option (right to buy)	0			Jan 23, 2024	Direct	Common Stock

Showing 1 to 3 of 3 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.